{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:08:21Z","timestamp":1772575701265,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":5790,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1093\/annonc\/mdh089","type":"journal-article","created":{"date-parts":[[2004,3,3]],"date-time":"2004-03-03T14:13:19Z","timestamp":1078323199000},"page":"455-459","source":"Crossref","is-referenced-by-count":57,"title":["Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis"],"prefix":"10.1016","volume":"15","author":[{"given":"S.M.","family":"Ali","sequence":"first","affiliation":[]},{"given":"L.M.","family":"Demers","sequence":"additional","affiliation":[]},{"given":"K.","family":"Leitzel","sequence":"additional","affiliation":[]},{"given":"H.A.","family":"Harvey","sequence":"additional","affiliation":[]},{"given":"D.","family":"Clemens","sequence":"additional","affiliation":[]},{"given":"N.","family":"Mallinak","sequence":"additional","affiliation":[]},{"given":"L.","family":"Engle","sequence":"additional","affiliation":[]},{"given":"V.","family":"Chinchilli","sequence":"additional","affiliation":[]},{"given":"L.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"C.","family":"Brady","sequence":"additional","affiliation":[]},{"given":"J.","family":"Seaman","sequence":"additional","affiliation":[]},{"given":"A.","family":"Lipton","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh089_bb0010","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.1991.9.12.2153","article-title":"Factors predicting response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: A prospective Eastern Cooperative group study","volume":"9","author":"Falkson","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh089_bb0015","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1200\/JCO.1992.10.8.1284","article-title":"Prognostic significance of estrogen receptor levels in estrogen receptor positive patients with metastatic breast cancer treated with Tamoxifen: Results of a prospective Southwest Oncology group study","volume":"10","author":"Ravdin","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh089_bb0020","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/1097-0142(19900915)66:14+<1439::AID-CNCR2820661421>3.0.CO;2-M","article-title":"Comprehensive management of disseminated breast cancer","volume":"66","author":"Henderson","year":"1990","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh089_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdh089_bb0030","first-page":"97","article-title":"The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease","volume":"80","author":"Pecherstorfer","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdh089_bb0035","first-page":"2221","article-title":"Usefulness of pyridinium cross links and CA 15-3 as markers in metastatic bone breast carcinoma","volume":"16","author":"Massidda","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1093\/annonc\/mdh089_bb0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/clinchem\/39.4.614","article-title":"Increased urinary excretion of pyridinium cross-links in cancer patients","volume":"39","author":"Lipton","year":"1993","journal-title":"Clin Chem"},{"key":"10.1093\/annonc\/mdh089_bb0045","first-page":"2289","article-title":"Serum concentrations of type I collagen carboxy terminal telopeptide (ICTP) and type I procollagen carboxy and amino terminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer","volume":"16","author":"Tahtela","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1093\/annonc\/mdh089_bb0050","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/clinchem\/41.10.1489","article-title":"Biochemical markers of bone turnover in patients with metastatic bone disease","volume":"41","author":"Demers","year":"1995","journal-title":"Clin Chem"},{"key":"10.1093\/annonc\/mdh089_bb0055","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring human bone reposition: quantitation of type 1 collagen cross-linked N-telopeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdh089_bb0060","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2503::AID-CNCR13>3.0.CO;2-W","article-title":"Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials","volume":"77","author":"Buzdar","year":"1996","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh089_bb0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/bjc.1998.52","article-title":"The clinical course of bone metastasis and prognostic factors following recurrence from breast cancer","volume":"77","author":"Coleman","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdh089_bb0070","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1200\/JCO.1997.15.10.3171","article-title":"Impact of selection process on response rate and long-term survival of potential high dose chemotherapy candidates treated with standard-dose doxorubicin containing chemotherapy in patients with metastatic breast cancer","volume":"15","author":"Rahman","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh089_bb0075","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1200\/JCO.2001.19.10.2596","article-title":"Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the international letrozole breast cancer group","volume":"19","author":"Mouridsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh089_bb0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.1999.17.1.64","article-title":"Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741","volume":"17","author":"Abrams","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh089_bb0085","doi-asserted-by":"crossref","first-page":"26508","DOI":"10.1074\/jbc.271.43.26508","article-title":"Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone","volume":"271","author":"Hanson","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdh089_bb0090","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/clinchem\/43.11.2058","article-title":"Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption","volume":"43","author":"Clemens","year":"1997","journal-title":"Clin Chem"},{"key":"10.1093\/annonc\/mdh089_bb0095","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z","article-title":"Biochemical markers and skeletal metastases. [Review]","volume":"88","author":"Demers","year":"2000","journal-title":"Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/3\/455\/557653\/mdh089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T21:15:11Z","timestamp":1582233311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419641372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0923753419641372"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh089","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}